Abstract:The development of activatable photosensitizers to allow for the reversible control of singlet oxygen (1O2) production for photodynamic therapy (PDT) faces great challenges. Fortunately, the flourishing field of supramolecular biotechnology provides more effective strategies for activatable PDT systems. Here, we developed a new reversible PDT on a switch that controls the 1O2 generation of self-assembled albumin nanotheranostics in vitro and in vivo. A new molecular design principle of aggregation-induced self-quenching photochromism and albumin on-photoswitching was demonstrated using a new asymmetric, synthetic diarylethene moiety DIA. The photosensitizer porphyrin and DIA were incorporated as building blocks in a glutaraldehyde-induced covalent albumin cross-linking nanoplatform, HSA–DIA–porphyrin nanoparticles (NPs). More importantly, the excellent photoswitching property of DIA enables the resultant nanoplatform to act as a facile, switchable strategy for photodynamic-immunotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c12851?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c12851</a>.Discussions of materials and methods used, synthetic protocols, synthesis and optimization of HSA–DIA–porphyrin nanoparticles, 1O2 measurement, cell cultures, CLSM evaluation, in vivo PDT treatment and pathology analysis, abscopal effect on 4T1 tumor-bearing mice, and mechanism investigation of the in vivo combined therapy, figures of synthetic pathway, 1H NMR and HRMS spectra, DIA pictures, NanoDIA in different concentrations, absorption spectra, absorption changes, parallel and antiparallel conformations structures, energy-minimized structures, binding modes, free energy of binding, fluorescence spectra, flow cytometric profiles and corresponding quantitative results, cell viability, histological analysis, morbidity-free survival rate, and histograms depicting variations in the routine blood test and kidney functional markers test, table of binding energies (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c12851/suppl_file/ja0c12851_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Zinc‐Substituted Hemoglobin‐Albumin Cluster as a Porphyrin‐Carrier for Enhanced Photodynamic Therapy

Synthesis of Hemoglobin Conjugated Polymeric Micelle: A ZnPc Carrier with Oxygen Self-Compensating Ability for Photodynamic Therapy.

Triphenylamine-substituted Zinc Porphyrin Nanoparticles with Photodynamic/photothermal Activity for Cancer Phototherapy in Vitro

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

Synthesis of Asymmetric Cationic Zinc Porphyrin Photosensitizer Containing Thiophene Group for Photodynamic Therapy in Vitro and Theoretical Calculation of DFT

Interaction between a water-soluble anionic porphyrin and human serum albumin unexpectedly stimulates the aggregation of the photosensitizer at the surface of the albumin

Correction To: Carbon Dots @ Platinum Porphyrin Composite As Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy

Platinated Porphyrin As A New Organelle and Nucleus Dual-Targeted Photosensitizer for Photodynamic Therapy

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

Synthesis, singlet oxygen generation, photocytotoxicity and subcellular localization of azobisporphyrins as potentially photodynamic therapeutic agents in vitro cell study

Organic Small Molecular Nanoparticles Based on Self-Assembly of Amphiphilic Fluoroporphyrins for Photodynamic and Photothermal Synergistic Cancer Therapy.

pH-responsive Photinia glabra-zinc oxide-protoporphyrin IX nanoconjugates with enhanced cellular uptake for photodynamic therapy towards cancer cells

A Metal Protoporphyrin-Induced Nano-Self-Assembly For Potentiating Photothermal Therapy By Depleting Antioxidant Defense Systems

Protein-Activatable Diarylethene Monomer as a Smart Trigger of Noninvasive Control Over Reversible Generation of Singlet Oxygen: A Facile, Switchable, Theranostic Strategy for Photodynamic-Immunotherapy

Triple-Function Porphyrin in Glycopolymeric Photosensitizer: From PhotoATRP to Targeted PDT

A photosensitizer loaded hemoglobin–polymer conjugate as a nanocarrier for enhanced photodynamic therapy

A Porphyrin-Based Metallacage for Enhanced Photodynamic Therapy.

Nanoscale Metal–Organic Framework Confines Zinc-Phthalocyanine Photosensitizers for Enhanced Photodynamic Therapy

Synthesis of Three Cisplatin-Conjugated Asymmetric Porphyrin Photosensitizers for Photodynamic Therapy.

Optical Behaviors of Zno-Porphyrin Conjugates and Their Potential Applications for Cancer Treatment

Β‐ionic Conjugated Chlorin‐Type Photosensitizers Based on Porpholactone: Synthesis, Photophysical Properties, and Photodynamic Activity